Inventor · disambiguated record
David Epstein
Also filed as: EPSTEIN DAVID · EPSTEIN DAVID L
25 granted patents·17 pending applications·506 citations·filing 1986–2021
97Inventor score
Top patents by PatentIndex Score
42 records- 0193US7538211B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted May 26, 2009·33 cites·7 claims
- 0292US7803931B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted Sep 28, 2010·19 cites·5 claims
- 0392US7579456B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2006·Granted Aug 25, 2009·24 cites·6 claims
- 0490US7125660B2Nucleic acid sensor molecules and methods of using sameARCHEMIX CORP·Filed 2002·Granted Oct 24, 2006·77 cites·54 claims
- 0589US6534082B1Method of treating disorders of the eyeUNIV DUKE·Filed 2000·Granted Mar 18, 2003·23 cites·6 claims
- 0688US8236773B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2006·Granted Aug 7, 2012·9 cites·10 claims
- 0788US4757089AIncreasing aqueous humor outflowMASSACHUSETTS EYE & EAR INFIRM·Filed 1986·Granted Jul 12, 1988·90 cites·3 claims
- 0887US10947544B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2019·Granted Mar 16, 2021·1 cites·5 claims
- 0986US8436164B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2012·Granted May 7, 2013·6 cites·15 claims
- 1086US7960102B2Regulated aptamer therapeuticsARCHEMIX CORP·Filed 2005·Granted Jun 14, 2011·6 cites·8 claims
- 1184US9617546B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2014·Granted Apr 11, 2017·4 cites·5 claims
- 1284US5863948AIncreasing aqueous humor outflowMASSACHUSETTS EYE & EAR INFIRM·Filed 1994·Granted Jan 26, 1999·108 cites·3 claims
- 1377US11913000B2Aptamer therapeutics useful in the treatment of complement-related disordersIVERIC BIO INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 1476US5306731AMethod and products for treating the eyeMASSACHUSETTS EYE & EAR INFIRM·Filed 1991·Granted Apr 26, 1994·33 cites·27 claims
- 1575US8946184B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2013·Granted Feb 3, 2015·1 cites·20 claims
- 1674US10100316B2Aptamers comprising CPG motifsEPSTEIN DAVID·Filed 2004·Granted Oct 16, 2018·4 cites·14 claims
- 1773US8415364B2Method of preventing or treating glaucomaEPSTEIN DAVID L·Filed 2004·Granted Apr 9, 2013·11 cites·20 claims
- 1873US5458883AMethod of treating disorders of the eyeUNIV DUKE·Filed 1994·Granted Oct 17, 1995·20 cites·11 claims
- 1968US9303262B2Methods for identifying aptamer regulatorsWILSON CHARLES·Filed 2003·Granted Apr 5, 2016·1 cites·8 claims
- 2064US6126957AMethod of treating disorders of the eyeUNIV DUKE·Filed 1995·Granted Oct 3, 2000·15 cites·6 claims
- 2162US2018030446A1Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2017·Application pending·0 cites
- 2261US10485550B2Ophthalmic drug delivery device and methods of useEPSTEIN DAVID L·Filed 2013·Granted Nov 26, 2019·1 cites·18 claims
- 2357US2004180360A1Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the sameFiled 2003·Application pending·0 cites
- 2455US8642644B2Ophthamological drugsTOONE ERIC J·Filed 2009·Granted Feb 4, 2014·0 cites·25 claims
- 2553US2004110235A1Regulated aptamer therapeuticsFiled 2003·Application pending·0 cites
- 2653US2007009476A1Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the sameWILSON CHARLES·Filed 2006·Application pending·0 cites
- 2753US2009269356A1Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular DisordersEPSTEIN DAVID·Filed 2007·Application pending·0 cites
- 2852US2009053138A1Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology TherapeuticsPREISS JEFFREY R·Filed 2005·Application pending·0 cites
- 2950US2004253243A1Aptamer therapeutics useful in ocular pharmacotherapyFiled 2004·Application pending·0 cites
- 3050US2004137429A1Therapeutic aptamers having binding specificity to gp41 of HIVFiled 2003·Application pending·0 cites
- 3149US2005124565A1Stabilized aptamers to platelet derived growth factor and their use as oncology therapeuticsFiled 2004·Application pending·0 cites
- 3246US2006135609A1Ophthamological drugsUNIV DUKE·Filed 2005·Application pending·0 cites
- 3345US2004018515A1Compositions selective for adenosine diphosphate and methods of using sameFiled 2003·Application pending·0 cites
- 3443US2015051557A1Devices and methods of administering opthalmic medicationsUNIV DUKE·Filed 2013·Application pending·0 cites
- 3543US2017145416A1Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular DisordersARCHEMIX LLC·Filed 2016·Application pending·0 cites
- 3641US2009018093A1Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease TherapeuticsCLOAD SHARON·Filed 2005·Application pending·0 cites
- 3740US2003087239A1Target activated nucleic acid biosensor and methods of using sameFiled 2001·Application pending·0 cites
- 3838US2018008718A1Compositions for the sustained release of anti-glaucoma agents to control intraocular pressureUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 3931US5020526AEye bottleEPSTEIN DAVID L·Filed 1989·Granted Jun 4, 1991·9 cites·7 claims
- 4030US5871127AAutomatically-venting dispensing capUNIV DUKE·Filed 1997·Granted Feb 16, 1999·5 cites·17 claims
- 4129US5342327AEye bottleEPSTEIN DAVID L·Filed 1993·Granted Aug 30, 1994·6 cites·6 claims
- 4226US2001053766A1Method of treating disorders of the eyeFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Epstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →